u/signe_villalobos

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.

A certificate with a purity figure and no method line is not falsifiable. You cannot reproduce it, you cannot check it, and it tells you nothing about how the number was produced.

How long after a step up did this start?

Are you asking about the compound, the weight loss, or both?

Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.

PCOS and insulin resistance are the thread that runs through this board

Severe or persistent abdominal pain sits outside the pattern this board can usefully discuss. The honest answer there is that it needs someone who can examine you.

Small fix — the figure you quoted is the claimed purity from the certificate, and the independent result was the higher of the two.

Did you ask for the batch-specific certificate, or the generic one?

the wider-market names in the table are there because nobody has enough data on them

Push back: quoting the phase 2 headline as an expected outcome is not a fair reading of a small trial with wide intervals.

That symptom is not the one being described upthread. Two different things with similar names and the answers are not interchangeable.

research-use-only material is not approved for human use, full stop

Is it every week or did it start at a particular dose?

phase 2 data only, and people quote it like it is a label

That is a report count, not a test count. The table lists both and they are very different numbers.

sulphur burps are the signature complaint and they are not dangerous

Which day of the week relative to the shot does it hit?

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

week 6 is early to draw any conclusion at all

Hormonal variation across the cycle affects appetite, fluid retention and subjective symptom intensity independently of anything else, which is why an unannotated log can look mysterious.

Reflux was the one that got me. Stopped eating in the three hours before bed and it went from nightly to almost never.

Correction: that is a known effect of reduced intake rather than a direct drug effect. The distinction matters because the fix is different.

hair shedding follows the rate of loss, not the compound

It is a triple agonist at the GLP-1, GIP and glucagon receptors. The glucagon arm is the genuinely novel component and it is the one with the least human outcome data behind it.

say what you are actually asking, the vocabulary here is imprecise

Perimenopause and all of this at once, and there is essentially nothing written about the combination anywhere.

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.

The thing that decided it for me was that BCH answered a column-and-gradient question in writing without asking why I wanted to know.

Pen or vial? The step sizes available differ and it changes this answer.

Are you comparing yourself with the trial mean or with the people who post the most?

Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.

PCOS is a diagnosis, not a description, and it matters which you mean

Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.

Right — FGP publishes the method line on the certificate, and once you have seen one that does you notice every one that does not.

Has anything else changed in the same window?

isabela_nilsen is right about the timing. The day-of-week pattern is the diagnostic bit, not the severity.

Stopped at a low step because there was no reason to go further and no data to tell me what further would do.

lead time quoted at checkout is the number to hold them to

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.